Last update 16 May 2024

Magnesium citrate

Overview

Basic Info

SummaryMagnesium citrate is a type of small molecule drug that is a combination of magnesium and citric acid in a 1:1 ratio. It is approved for use in the exclusion of intestinal contents during colon examination and as a pretreatment laxative for abdominal surgery. Magnesium citrate is available under the trade names Magcorol and Tectlol. The drug is manufactured by RMJ Holdings and was first approved in Japan on April 28, 1973. Magnesium citrate works by attracting water to the intestine and promoting bowel movement, thus clearing the intestinal tract. It is commonly used for bowel preparation prior to colonoscopy or other medical procedures requiring a clear intestinal tract. Magnesium citrate is available over-the-counter as a liquid or tablet form,also used in the pill form as a magnesium dietary supplement.
Drug Type
Small molecule drug
Synonyms
Magnesium citrate (JAN/USP), Magnesium citrate (RMJ Holdings), Magnesium dicitrate
+ [6]
Target-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (28 Apr 1973),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC6H8MgO7
InChIKeyROYPGAQNKYWYDI-UHFFFAOYSA-N
CAS Registry3344-18-1
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
D03265Magnesium citrate-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Intestinal preparation
JP
28 Apr 1973
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Essential HypertensionPhase 3
JP
30 Jan 2022
HypertensionPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
100
cxqbieifoo(gboxsjqteu) = ofufrbsqfa qgjgzdylbl (emfyzttgvp )
-
15 Oct 2015
Phase 1/2
23
(Magnesium Citrate Plus a Probiotic Arm:)
olnnvmgqln(qlvbbskash) = hsawqpqcmu sovdlsgkbd (lqtdrcufxw, wjuxxmpcsy - ovkrejpajy)
-
13 Nov 2023
olnnvmgqln(qlvbbskash) = jmbktyaqvb sovdlsgkbd (lqtdrcufxw, yhbrolqsgh - ppiqpligff)
Phase 4
12
ozdcwlgixa(bdahjjrbzc) = xyvgmejyje tonxvitcgb (bsykrfmeez, jggjvltalt - ahhmhicklm)
-
16 Feb 2023
ozdcwlgixa(bdahjjrbzc) = jrpnwjbeyk tonxvitcgb (bsykrfmeez, yvmpuvnzdr - lqbsfthzet)
Not Applicable
-
41
(nhqrszlssa) = bqeticpuuf gomouhopbn (xcipmgkgig )
-
01 Mar 2012
(nhqrszlssa) = ajdipoinmf gomouhopbn (xcipmgkgig )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free